7Baggers
 exicure hitron wins 1.7 billion won order  MarketScreener Mon, 29 Sep 2025 06:06:33 GMT
 published on: 2025-09-16 02:03:11  newser.com Tue, 16 Sep 2025 07:03:11 GMT

Exicure
(NASDAQ:XCUR) 

XCUR stock logo

Exicure, Inc., a clinical-stage biotechnology company, develops therapeutics for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. Its drug candidate includes cavrotolimod (AST-008) that is in a Phase 1b/2 clini...

Founded: 2011
CEO: David Giljohann  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends